Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys

C. D. Miles, D. E. Schaubel, X. Jia, A. O. Ojo, F. K. Port, P. S. Rao

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Nearly one-quarter of the kidney transplant waiting list is composed of repeat transplantation candidates. Survival following retransplantation using expanded criteria donor (ECD) kidneys has not been adequately studied. Using data from the Scientific Registry of Transplant Recipients, we analyzed mortality after retransplantation with ECD and non-ECD deceased-donor kidneys. Adult patients who experienced graft failure and were relisted for transplantation between 1995 and 2004 were studied (n = 9641). Follow-up began at the date of relisting and continued until death or the end of the observation period (December 31, 2004), with censoring at living-donor transplantation. Sequential stratification (an extension of Cox regression) was used to compare mortality between patients receiving an ECD retransplant and those remaining on the waiting list or receiving a non-ECD retransplant (conventional therapy). Of 2908 retransplantations, 292 used ECD kidneys. Survival after ECD retransplantation was approximately equal to that of conventional therapy, with an adjusted hazard ratio of 0.98 (p = 0.88). In contrast, non-ECD retransplant recipients experienced a significant reduction in mortality (HR = 0.44; p < 0.0001). Based on these national data, recipients of ECD retransplantation do not have a survival advantage relative to conventional therapy, whereas non-ECD retransplantation is associated with a significant survival advantage.

Original languageEnglish (US)
Pages (from-to)1140-1147
Number of pages8
JournalAmerican Journal of Transplantation
Volume7
Issue number5
DOIs
StatePublished - May 1 2007

Fingerprint

Transplantation
Tissue Donors
Kidney
Mortality
Waiting Lists
Survival
Transplants
Living Donors
Registries
Therapeutics
Observation

Keywords

  • Donor age
  • SRTR
  • Sequential stratification
  • Survival
  • Transplant benefit

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. / Miles, C. D.; Schaubel, D. E.; Jia, X.; Ojo, A. O.; Port, F. K.; Rao, P. S.

In: American Journal of Transplantation, Vol. 7, No. 5, 01.05.2007, p. 1140-1147.

Research output: Contribution to journalArticle

@article{eb6baadb77e54beaa31c6ceb9d6ab9b4,
title = "Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys",
abstract = "Nearly one-quarter of the kidney transplant waiting list is composed of repeat transplantation candidates. Survival following retransplantation using expanded criteria donor (ECD) kidneys has not been adequately studied. Using data from the Scientific Registry of Transplant Recipients, we analyzed mortality after retransplantation with ECD and non-ECD deceased-donor kidneys. Adult patients who experienced graft failure and were relisted for transplantation between 1995 and 2004 were studied (n = 9641). Follow-up began at the date of relisting and continued until death or the end of the observation period (December 31, 2004), with censoring at living-donor transplantation. Sequential stratification (an extension of Cox regression) was used to compare mortality between patients receiving an ECD retransplant and those remaining on the waiting list or receiving a non-ECD retransplant (conventional therapy). Of 2908 retransplantations, 292 used ECD kidneys. Survival after ECD retransplantation was approximately equal to that of conventional therapy, with an adjusted hazard ratio of 0.98 (p = 0.88). In contrast, non-ECD retransplant recipients experienced a significant reduction in mortality (HR = 0.44; p < 0.0001). Based on these national data, recipients of ECD retransplantation do not have a survival advantage relative to conventional therapy, whereas non-ECD retransplantation is associated with a significant survival advantage.",
keywords = "Donor age, SRTR, Sequential stratification, Survival, Transplant benefit",
author = "Miles, {C. D.} and Schaubel, {D. E.} and X. Jia and Ojo, {A. O.} and Port, {F. K.} and Rao, {P. S.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1111/j.1600-6143.2007.01742.x",
language = "English (US)",
volume = "7",
pages = "1140--1147",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys

AU - Miles, C. D.

AU - Schaubel, D. E.

AU - Jia, X.

AU - Ojo, A. O.

AU - Port, F. K.

AU - Rao, P. S.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Nearly one-quarter of the kidney transplant waiting list is composed of repeat transplantation candidates. Survival following retransplantation using expanded criteria donor (ECD) kidneys has not been adequately studied. Using data from the Scientific Registry of Transplant Recipients, we analyzed mortality after retransplantation with ECD and non-ECD deceased-donor kidneys. Adult patients who experienced graft failure and were relisted for transplantation between 1995 and 2004 were studied (n = 9641). Follow-up began at the date of relisting and continued until death or the end of the observation period (December 31, 2004), with censoring at living-donor transplantation. Sequential stratification (an extension of Cox regression) was used to compare mortality between patients receiving an ECD retransplant and those remaining on the waiting list or receiving a non-ECD retransplant (conventional therapy). Of 2908 retransplantations, 292 used ECD kidneys. Survival after ECD retransplantation was approximately equal to that of conventional therapy, with an adjusted hazard ratio of 0.98 (p = 0.88). In contrast, non-ECD retransplant recipients experienced a significant reduction in mortality (HR = 0.44; p < 0.0001). Based on these national data, recipients of ECD retransplantation do not have a survival advantage relative to conventional therapy, whereas non-ECD retransplantation is associated with a significant survival advantage.

AB - Nearly one-quarter of the kidney transplant waiting list is composed of repeat transplantation candidates. Survival following retransplantation using expanded criteria donor (ECD) kidneys has not been adequately studied. Using data from the Scientific Registry of Transplant Recipients, we analyzed mortality after retransplantation with ECD and non-ECD deceased-donor kidneys. Adult patients who experienced graft failure and were relisted for transplantation between 1995 and 2004 were studied (n = 9641). Follow-up began at the date of relisting and continued until death or the end of the observation period (December 31, 2004), with censoring at living-donor transplantation. Sequential stratification (an extension of Cox regression) was used to compare mortality between patients receiving an ECD retransplant and those remaining on the waiting list or receiving a non-ECD retransplant (conventional therapy). Of 2908 retransplantations, 292 used ECD kidneys. Survival after ECD retransplantation was approximately equal to that of conventional therapy, with an adjusted hazard ratio of 0.98 (p = 0.88). In contrast, non-ECD retransplant recipients experienced a significant reduction in mortality (HR = 0.44; p < 0.0001). Based on these national data, recipients of ECD retransplantation do not have a survival advantage relative to conventional therapy, whereas non-ECD retransplantation is associated with a significant survival advantage.

KW - Donor age

KW - SRTR

KW - Sequential stratification

KW - Survival

KW - Transplant benefit

UR - http://www.scopus.com/inward/record.url?scp=34247335090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247335090&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2007.01742.x

DO - 10.1111/j.1600-6143.2007.01742.x

M3 - Article

C2 - 17331109

AN - SCOPUS:34247335090

VL - 7

SP - 1140

EP - 1147

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 5

ER -